APTX News and Press, Aptinyx Inc. From 10/21/20

Gainers: [[ALGN]] +27.2%. [[BCOV]] +13.2%. [[SDC]] +10.4%. [[RLI]] +8.1%. [[MR]] +7.1%.Losers: [[WEI]] -11%. [[MRIN]] -10.1%. [[CLAR]] -6.8%. [[APTX]] -4.1%. [[CMG]] -3.9%. For further details see: ALGN, BCOV, WEI and APTX among after-hours movers

Shares of Aptinyx (NASDAQ: APTX) were sinking 7.2% lower as of 3:32 p.m. EDT on Wednesday after falling as much as 12.8% earlier in the day. The decline stemmed from the company's announcement on Tuesday evening that it plans to sell 12 million shares in a public stock offering. ...

Gainers: [[WEI]] +62.9%. [[SNAP]] +24.1%. [[CALX]] +12.9%. [[WDFC]] +10.4%. [[TCS]] +9.4%.Losers: [[NFLX]] -5.9%. [[APTX]] -4.3%. [[NAVI]] -4.0%. [[CWST]] -4.0%. [[IRBT]] -3.0%. For further details see: WEI, SNAP, NFLX and IRBT among after-hours movers

Aptinyx (APTX) to offer 12M common shares in an underwritten public offering. Underwriters have an option to purchase up to an additional 1.8M shares.Price for the offering is yet to be determined. For further details see: Aptinyx launches equity offering

Gainers: Cleveland BioLabs (CBLI) +66%.9F (JFU) +47%.Molecular Data (MKD) +35%.Natuzzi (NTZ) +30%.Aptinyx (APTX) +26%.VOXX International (VOXX) +23%.Pro-Dex (PDEX) +21%.SunLink Health Systems (SSY) +21%.China Index Holdings (CIH) +14%.Anchiano Therapeutics (ANCN) +11%.Losers: Kaixin...

Gainers: Cleveland BioLabs (CBLI) +96%, Anchiano Therapeutics (ANCN) +46%, Aptinyx (APTX) +45%, SOS (SOS) +21%, Liquidia Technologies (LQDA) +18%.Losers: Baudax Bio (BXRX) -37%, BOQI International Medical (BIMI) -13%, Midatech Pharma (MTP) -11...

Shares of the clinical-stage biotech Aptinyx (NASDAQ: APTX) are up by an eye-catching 55% as of 9:55 a.m. Tuesday morning. The drugmaker's stock is ripping higher in response to a positive midstage trial for its post-traumatic stress disorder (PTSD) candidate known as NYX-783. B...

Aptinyx (APTX) +98% on reporting positive top-line data from Phase 2 study of NYX-783.Cleveland BioLabs (CBLI) +46% in reaction to its planned merger with biopharmaceutical outfit Cytocom.Recon Technology (RCON) +42%.ATIF Holdings (ATIF) +26% after entering into ...

Gainers: [[APTX]] +89.3%. [[EMKR]] +14.8%. [[GNMK]] +8.9%. [[CCK]] +6.5%. [[NOK]] +3.8%.Losers: [[RAIL]] -9.6%. [[HXL]] -8.8%. [[BLU]] -6.9%. [[STLD]] -3.4%. [[TEO]] -3.3%. For further details see: APTX, GNMK, HXL and RAIL among after-hours movers

Thinly traded micro cap Aptinyx (APTX) jumps 49% after hours in reaction to positive results from a Phase 2 clinical trial evaluating NYX-783 in 153 patients with posttraumatic stress disorder ((PTSD)).NYX-783, an NMDA receptor modulator, showed statistically significant and clinica...